October 03, 2022
2 min watch
Save
VIDEO: Physicians should consider methicillin resistance when treating eye infections
Issue: November 10, 2022
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
CHICAGO — In this Healio Video Perspective from the AAO meeting, Penny A. Asbell, MD, MBA, discusses the ARMOR study, the largest surveillance study of eye infections in the U.S.
“Methicillin resistance may be a little bit better than it was 10 years ago, but it is still here,” she said. “Multidrug resistance is still here and is something you should be thinking about when you pick that antibiotic and take care of your patient.”
Published by:
Sources/Disclosures
Collapse
Source:
Asbell PA, et al. Longitudinal analysis of in vitro antibiotic resistance rates among bacterial pathogens collected in the ARMOR study. Presented at: American Academy of Ophthalmology meeting; Sept. 30-Oct. 3, 2022; Chicago.
Disclosures:
Asbell reports conducting a CME presentation for Bausch + Lomb.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.